DK1635855T3 - Selektive R-cadherin-antagonister og fremgangsmåder - Google Patents
Selektive R-cadherin-antagonister og fremgangsmåderInfo
- Publication number
- DK1635855T3 DK1635855T3 DK04750884.1T DK04750884T DK1635855T3 DK 1635855 T3 DK1635855 T3 DK 1635855T3 DK 04750884 T DK04750884 T DK 04750884T DK 1635855 T3 DK1635855 T3 DK 1635855T3
- Authority
- DK
- Denmark
- Prior art keywords
- amino acid
- cadherin
- peptide
- selective
- xaa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46718803P | 2003-05-01 | 2003-05-01 | |
PCT/US2004/013212 WO2004099232A2 (en) | 2003-05-01 | 2004-04-30 | Selective r-cadherin antagonists and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1635855T3 true DK1635855T3 (da) | 2011-02-14 |
Family
ID=33435033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04750884.1T DK1635855T3 (da) | 2003-05-01 | 2004-04-30 | Selektive R-cadherin-antagonister og fremgangsmåder |
Country Status (18)
Country | Link |
---|---|
US (2) | US7419953B2 (da) |
EP (1) | EP1635855B1 (da) |
JP (1) | JP4613300B2 (da) |
KR (2) | KR101120419B1 (da) |
CN (2) | CN1812804B (da) |
AT (1) | ATE491718T1 (da) |
AU (1) | AU2004236208B2 (da) |
BR (1) | BRPI0409850A (da) |
CA (1) | CA2523932A1 (da) |
DE (1) | DE602004030565D1 (da) |
DK (1) | DK1635855T3 (da) |
ES (1) | ES2355260T3 (da) |
MX (1) | MXPA05011751A (da) |
PL (1) | PL1635855T3 (da) |
PT (1) | PT1635855E (da) |
RU (1) | RU2349598C2 (da) |
WO (1) | WO2004099232A2 (da) |
ZA (1) | ZA200509708B (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277824B1 (en) * | 1998-07-10 | 2001-08-21 | Adherex Technologies | Compounds and methods for modulating adhesion molecule function |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7803904B2 (en) * | 1995-09-01 | 2010-09-28 | Millennium Pharmaceuticals, Inc. | Mucosal vascular addressing and uses thereof |
EP0808367B1 (en) * | 1995-02-10 | 2007-07-11 | Millennium Pharmaceuticals, Inc. | Mucosal vascular addressins and uses thereof |
WO1999057149A2 (en) * | 1998-05-05 | 1999-11-11 | Adherex Technologies, Inc. | Compounds and methods for modulating nonclassical cadherin-mediated functions |
US6277824B1 (en) * | 1998-07-10 | 2001-08-21 | Adherex Technologies | Compounds and methods for modulating adhesion molecule function |
US20020151681A1 (en) * | 1999-03-12 | 2002-10-17 | Rosen Craig A. | Nucleic acids, proteins and antibodies |
US7267942B2 (en) * | 2003-03-24 | 2007-09-11 | The University Of Hong Kong | Diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
-
2004
- 2004-04-30 MX MXPA05011751A patent/MXPA05011751A/es active IP Right Grant
- 2004-04-30 KR KR1020117019034A patent/KR101120419B1/ko not_active IP Right Cessation
- 2004-04-30 KR KR1020057020759A patent/KR101138633B1/ko not_active IP Right Cessation
- 2004-04-30 PT PT04750884T patent/PT1635855E/pt unknown
- 2004-04-30 EP EP04750884A patent/EP1635855B1/en not_active Expired - Lifetime
- 2004-04-30 BR BRPI0409850-1A patent/BRPI0409850A/pt active Search and Examination
- 2004-04-30 AT AT04750884T patent/ATE491718T1/de active
- 2004-04-30 CN CN2004800184052A patent/CN1812804B/zh not_active Expired - Fee Related
- 2004-04-30 DK DK04750884.1T patent/DK1635855T3/da active
- 2004-04-30 CA CA002523932A patent/CA2523932A1/en not_active Abandoned
- 2004-04-30 AU AU2004236208A patent/AU2004236208B2/en not_active Ceased
- 2004-04-30 DE DE602004030565T patent/DE602004030565D1/de not_active Expired - Lifetime
- 2004-04-30 CN CN2013101708624A patent/CN103272219A/zh active Pending
- 2004-04-30 JP JP2006513429A patent/JP4613300B2/ja not_active Expired - Fee Related
- 2004-04-30 WO PCT/US2004/013212 patent/WO2004099232A2/en active Application Filing
- 2004-04-30 ES ES04750884T patent/ES2355260T3/es not_active Expired - Lifetime
- 2004-04-30 PL PL04750884T patent/PL1635855T3/pl unknown
- 2004-04-30 US US10/836,289 patent/US7419953B2/en not_active Expired - Fee Related
- 2004-04-30 RU RU2005137322/04A patent/RU2349598C2/ru not_active IP Right Cessation
-
2005
- 2005-11-30 ZA ZA200509708A patent/ZA200509708B/en unknown
-
2008
- 2008-09-02 US US12/231,328 patent/US8163697B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2004099232A2 (en) | 2004-11-18 |
CA2523932A1 (en) | 2004-11-18 |
US7419953B2 (en) | 2008-09-02 |
KR101138633B1 (ko) | 2012-07-04 |
US8163697B2 (en) | 2012-04-24 |
KR20110099065A (ko) | 2011-09-05 |
US20090124538A1 (en) | 2009-05-14 |
JP2006525344A (ja) | 2006-11-09 |
CN1812804A (zh) | 2006-08-02 |
KR101120419B1 (ko) | 2012-03-16 |
EP1635855B1 (en) | 2010-12-15 |
JP4613300B2 (ja) | 2011-01-12 |
DE602004030565D1 (de) | 2011-01-27 |
BRPI0409850A (pt) | 2006-05-09 |
PL1635855T3 (pl) | 2011-04-29 |
EP1635855A2 (en) | 2006-03-22 |
EP1635855A4 (en) | 2007-10-10 |
RU2349598C2 (ru) | 2009-03-20 |
US20050004013A1 (en) | 2005-01-06 |
ATE491718T1 (de) | 2011-01-15 |
KR20060009283A (ko) | 2006-01-31 |
ES2355260T3 (es) | 2011-03-24 |
PT1635855E (pt) | 2011-02-23 |
MXPA05011751A (es) | 2006-02-17 |
AU2004236208B2 (en) | 2009-10-29 |
CN103272219A (zh) | 2013-09-04 |
RU2005137322A (ru) | 2006-06-10 |
AU2004236208A1 (en) | 2004-11-18 |
ZA200509708B (en) | 2006-12-27 |
CN1812804B (zh) | 2013-06-12 |
WO2004099232A3 (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koivunen et al. | Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins | |
Dennis et al. | Binding interactions of kistrin with platelet glycoprotein IIb‐IIIa: Analysis by site‐directed mutagenesis | |
ATE417595T1 (de) | Keratin-bindende polypeptide | |
WO2006012366A3 (en) | Methods for making and using recombinant bacillus thuringiensis spores | |
ATE469913T1 (de) | Antagonisten des nogo-rezeptors | |
CO5660297A2 (es) | Anticuerpos contra el receptor de il-21 humano y usos de los mismos | |
DK1761553T3 (da) | MHC molecule-binding tumor-associated peptides | |
WO2003039491A8 (en) | Novel isoforms of vascular endothelial cell growth inhibitor | |
Pan et al. | Total synthesis and stereochemical assignment of gymnopeptides A and B | |
ATE466874T1 (de) | Mit scytovirin der domäne 1 verwandte polypeptide | |
DE60214676D1 (de) | Hochaffine antagonisten der elr-cxc chemokine | |
DK1635855T3 (da) | Selektive R-cadherin-antagonister og fremgangsmåder | |
WO2005072766A3 (en) | Peptides that bind to hsp90 proteins | |
DK1417222T3 (da) | Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop | |
WO2007066018A3 (fr) | Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques | |
Zhou et al. | A novel disintegrin, jerdonatin, inhibits platelet aggregation and sperm–egg binding | |
WO2019046446A3 (en) | COMPOSITIONS AND METHODS USING METHANOTROPHE LAYER PROTEINS FOR THE EXPRESSION OF HETEROLOGOUS PROTEINS | |
WO2004056316A3 (en) | Vaccines against hiv-1 tat protein to generate neutralizing antibodies | |
WO2002066494A8 (en) | Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade | |
JP2016514459A5 (da) | ||
ATE390481T1 (de) | Modifizierte tridegine, ihre herstellung und verwendung als transglutaminase-inhibitoren | |
DE602004027272D1 (de) | Cyclische peptide, die als urotensin-ii-antagonisten wirken | |
Zhu et al. | Engineering novel anticoagulant proteins by motif grafting | |
WO2002033104A3 (en) | Antibiotic-based gene regulation system | |
WO2002102848A3 (en) | Nucleic acid and amino acid sequences of a vegf variant |